|
AKAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.63891122895166E-12 |
| Normal-vs-Stage2 |
8.12530043248216E-11 |
| Normal-vs-Stage3 |
1.50150003541683E-10 |
| Normal-vs-Stage4 |
1.85080000214555E-08 |
| Stage1-vs-Stage2 |
3.674000E-01 |
| Stage1-vs-Stage3 |
2.319700E-02 |
| Stage1-vs-Stage4 |
8.973400E-01 |
| Stage2-vs-Stage3 |
4.243400E-01 |
| Stage2-vs-Stage4 |
6.638400E-01 |
| Stage3-vs-Stage4 |
2.933800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
1.97530000001223E-06 |
| Caucasian-vs-AfricanAmerican |
6.316400E-01 |
| Caucasian-vs-Asian |
5.509600E-01 |
| AfricanAmerican-vs-Asian |
5.784600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
1.64435132177232E-12 |
| Male-vs-Female |
3.152300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.62481139653892E-12 |
| Normal-vs-Extreme_Weight |
1.68343117223912E-12 |
| Normal-vs-Obese |
3.33066907387547E-16 |
| Normal-vs-Extreme_Obese |
7.44648787076585E-12 |
| Normal_Weight-vs-Extreme_Weight |
8.018400E-01 |
| Normal_Weight-vs-Obese |
2.853000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.704800E-01 |
| Extreme_Weight-vs-Obese |
2.682200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.411200E-01 |
| Obese-vs-Extreme_Obese |
1.316590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.40150000005335E-06 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
3.99680288865056E-15 |
| Normal-vs-Age(81-100Yrs) |
1.62658775337832E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.773770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.962150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.777800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.756000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.802900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.106010E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.43689570931383E-15 |
| Normal-VS-Type2 PRCC |
1.64002145197628E-12 |
| Normal-VS-KIRP CIMP |
4.997000E-03 |
| Normal-VS-Unclassified PRCC |
5.10760322924853E-11 |
| Type1 PRCC-VS-Type2 PRCC |
2.715600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.935860E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.132460E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.178000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.610000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.148400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
7.44539999653071E-08 |
| Normal-vs-N2 |
3.551400E-04 |
| N0-vs-N1 |
3.151700E-02 |
| N0-vs-N2 |
5.841400E-01 |
| N1-vs-N2 |
5.499600E-01 |
|
|
